511
Views
19
CrossRef citations to date
0
Altmetric
Review Article

The association of platelets with failed patent ductus arteriosus closure after a primary course of indomethacin or ibuprofen: a systematic review and meta-analysis

, , &
Pages 127-133 | Received 25 Jan 2016, Accepted 05 Mar 2016, Published online: 14 Apr 2016

References

  • Gournay V. The ductus arteriosus: physiology, regulation, and functional and congenital anomalies. Arch Cardiovasc Dis 2011;104:578–85.
  • Benitz WE, Committee on fetus and newborn. Patent ductus arteriosus in preterm infants. Pediatrics 2016;137:1–6
  • Silver MM, Freedom RM, Silver MD, Olley PM. The morphology of the human newborn ductus arteriosus: a reappraisal of its structure and closure with special reference to prostaglandin E1 therapy. Hum Pathol 1981;12:1123–36.
  • Echtler K, Stark K, Lorenz M, et al Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 2010;16:75–82.
  • Simon SR, van Zogchel L, Bas-Suárez MP, et al Platelet counts and patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology 2015;108:143–51.
  • Mitra S, Rønnestad A, Holmstrøm H. Management of patent ductus arteriosus in preterm infants-where do we stand? Congenit Heart Dis 2013;8:500–12.
  • Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2010;7:CD000174.
  • Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2013;4:CD003481.
  • Reese J, Veldman A, Shah L, et al Inadvertent relaxation of the ductus arteriosus by pharmacological agents that are commonly used in the neonatal period. Semin Perinatol 2010;34:222–30.
  • Madan J, Fiascone J, Balasubramanian V, et al Predictors of ductal closure and intestinal complications in very low birth weight infants treated with indomethacin. Neonatology 2008;94:45–51.
  • Boo NY, Mohd-Amin I, Bilkis AA, Yong-Junina F. Predictors of failed closure of patent ductus arteriosus with indomethacin. Singapore Med J 2006;47:763–8.
  • Fendler W, Bernas S, Jarosik K, Piotrowski A. Is it possible to predict the success of pharmacological closure of persistent ductus arteriosus in prematurely born neonates? Anestezjol Intens Ter 2008;40:156–61.
  • Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2008;23:CD000503.
  • Green TP, Thompson TR, Johnson DE, Lock JE. Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome. N Engl J Med 1983;308:743–8.
  • Barefield ES, Dwyer MD, Cassady G. Association of patent ductus arteriosus and phototherapy in infants weighing less than 1000 grams. J Perinatol 1993;13:376–80.
  • Mitra S, Wahab MG. Indomethacin dose-interruption and maternal chorioamnionitis are risk factors for indomethacin treatment failure in preterm infants with patent ductus arteriosus. J Clin Neonatol 2015;4:250–5.
  • Lago P, Salvadori S, Opocher F, et al Continuous infusion of ibuprofen for treatment of patent ductus arteriosus in very low birth weight infants. Neonatology 2014;105:46–54.
  • Roberts I, Murray N. Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed 2003;88:359–64.
  • Wells GA, Shea B, O’Connell D, et al The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Department of Epidemiology and Community Medicine, University of Ottawa. 2009. Available from http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm [last accessed 21 Dec 2015].
  • Mitra S, Aune D, Speer CP, Saugstad OD. Chorioamnionitis as a risk factor for retinopathy of prematurity: a systematic review and meta-analysis. Neonatology 2014;105:189–99.
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–88.
  • Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–58.
  • Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088–101.
  • Dizdar EA, Ozdemir R, Sari FN, et al Low platelet count is associated with ductus arteriosus patency in preterm newborns. Early Hum Dev 2012;88:813–6.
  • Shah NA, Hills NK, Waleh N, et al Relationship between circulating platelet counts and ductus arteriosus patency after indomethacin treatment. J Pediatr 2011;158:919–23. e1-2
  • Schena F, Ciarmoli E, Ghirardello MS, et al A low platelet count is associated with treatment failurein preterm infants treated with ibuprofen for patent ductus arteriosus (PDA). Pediatr Res 2010;68:118–9.
  • Dani C, Poggi C, Fontanelli G. Relationship between platelet count and volume and spontaneous and pharmacological closure of ductus arteriosus in preterm infants. Am J Perinatol 2013;30:359–64.
  • Ahamed MF, Verma P, Lee S, et al Predictors of successful closure of patent ductus arteriosus with indomethacin. J Perinatol 2015;35:729–34.
  • Bas-Suárez MP, Gonzalez-Luis GE, Saavedra P, Villamor E. Platelet counts in the first seven days of life and patent ductus arteriosus in preterm very low-birth-weight infants. Neonatology 2014;106:188–94.
  • Clyman R, Chemtob S. Vessel remodeling in the newborn: platelets fill the gap. Nat Med 2010;16:33–5.
  • Goldbarg S, Quinn T, Waleh N, et al Effects of hypoxia, hypoglycemia, and muscle shortening on cell death in the sheep ductus arteriosus. Pediatr Res 2003;54:204–11.
  • Kajino H, Goldbarg S, Roman C, et al Vasa vasorum hypoperfusion is responsible for medial hypoxia and anatomic remodeling in the newborn lamb ductus arteriosus. Pediatr Res 2002;51:228–35.
  • Waleh N, Hodnick R, Jhaveri N, et al Patterns of gene expression in the ductus arteriosus are related to environmental and genetic risk factors for persistent ductus patency. Pediatr Res 2010;68:292–7.
  • Waleh N, Seidner S, McCurnin D, et al Anatomic closure of the premature patent ductus arteriosus: The role of CD14+/CD163+ mononuclear cells and VEGF in neointimal mound formation. Pediatr Res 2011;70:332–8.
  • Thebaud B, Wu XC, Kajimoto H, et al Developmental absence of the O2 sensitivity of L-type calcium channels in preterm ductus arteriosus smooth muscle cells impairs O2 constriction contributing to patent ductus arteriosus. Pediatr Res 2008;63:176–81.
  • Chen JX, O'Mara PW, Poole SD, et al Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus. Pediatr Res 2012;72:122–8.
  • Sallmon H, Weber SC, Huning B, et al Thrombocytopenia in the first 24 h after birth and incidence of patent ductus arteriosus. Pediatrics 2012;130:e623–30.
  • Murray NA. Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit. Acta Paediatr Suppl 2002;91:74–81.
  • Gonzalez A, Sosenko IR, Chandar J, et al Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 1996;128:470–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.